T. Rowe Price Associates
EXAS icon

T. Rowe Price Associates’s Exact Sciences EXAS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$197M Sell
3,703,265
-2,700,607
-42% -$144M 0.02% 433
2025
Q1
$277M Buy
6,403,872
+643,631
+11% +$27.9M 0.03% 360
2024
Q4
$324M Buy
5,760,241
+2,462,165
+75% +$138M 0.04% 339
2024
Q3
$225M Buy
3,298,076
+2,112,953
+178% +$144M 0.03% 415
2024
Q2
$50.1M Sell
1,185,123
-160,115
-12% -$6.76M 0.01% 724
2024
Q1
$92.9M Sell
1,345,238
-99,410
-7% -$6.87M 0.01% 568
2023
Q4
$107M Sell
1,444,648
-238,686
-14% -$17.7M 0.01% 528
2023
Q3
$115M Sell
1,683,334
-498,552
-23% -$34M 0.02% 486
2023
Q2
$205M Buy
2,181,886
+402,314
+23% +$37.8M 0.03% 387
2023
Q1
$121M Sell
1,779,572
-3,212,795
-64% -$218M 0.02% 477
2022
Q4
$247M Sell
4,992,367
-821,810
-14% -$40.7M 0.04% 335
2022
Q3
$189M Sell
5,814,177
-9,608,207
-62% -$312M 0.03% 369
2022
Q2
$607M Sell
15,422,384
-3,757,848
-20% -$148M 0.08% 253
2022
Q1
$1.34B Buy
19,180,232
+5,392,099
+39% +$377M 0.14% 153
2021
Q4
$1.07B Sell
13,788,133
-4,716,911
-25% -$367M 0.1% 208
2021
Q3
$1.77B Sell
18,505,044
-1,284,299
-6% -$123M 0.17% 126
2021
Q2
$2.46B Buy
19,789,343
+1,495,404
+8% +$186M 0.23% 96
2021
Q1
$2.41B Buy
18,293,939
+1,745,691
+11% +$230M 0.24% 93
2020
Q4
$2.19B Sell
16,548,248
-3,499,330
-17% -$464M 0.23% 98
2020
Q3
$2.04B Sell
20,047,578
-1,401,053
-7% -$143M 0.24% 89
2020
Q2
$1.86B Sell
21,448,631
-333,955
-2% -$29M 0.23% 90
2020
Q1
$1.26B Buy
21,782,586
+3,083,995
+16% +$179M 0.2% 110
2019
Q4
$1.73B Buy
18,698,591
+7,079,210
+61% +$655M 0.22% 101
2019
Q3
$1.05B Buy
11,619,381
+4,434,780
+62% +$401M 0.15% 150
2019
Q2
$848M Sell
7,184,601
-1,108,575
-13% -$131M 0.12% 190
2019
Q1
$718M Sell
8,293,176
-1,565,146
-16% -$136M 0.11% 204
2018
Q4
$622M Sell
9,858,322
-1,042,185
-10% -$65.8M 0.11% 201
2018
Q3
$860M Buy
10,900,507
+4,297,878
+65% +$339M 0.13% 179
2018
Q2
$395M Buy
6,602,629
+6,552,486
+13,068% +$392M 0.06% 308
2018
Q1
$2.02M Buy
50,143
+12,770
+34% +$515K ﹤0.01% 1567
2017
Q4
$1.96M Buy
37,373
+50
+0.1% +$2.63K ﹤0.01% 1573
2017
Q3
$1.76M Buy
37,323
+15
+0% +$707 ﹤0.01% 1588
2017
Q2
$1.32M Sell
37,308
-199,434
-84% -$7.06M ﹤0.01% 1676
2017
Q1
$5.59M Sell
236,742
-2,258
-0.9% -$53.3K ﹤0.01% 1415
2016
Q4
$3.19M Sell
239,000
-23,700
-9% -$317K ﹤0.01% 1472
2016
Q3
$4.88M Buy
262,700
+6,000
+2% +$111K ﹤0.01% 1431
2016
Q2
$3.15M Buy
256,700
+20,500
+9% +$251K ﹤0.01% 1454
2016
Q1
$1.59M Sell
236,200
-306,900
-57% -$2.07M ﹤0.01% 1577
2015
Q4
$5.01M Buy
543,100
+46,000
+9% +$425K ﹤0.01% 1418
2015
Q3
$8.94M Sell
497,100
-14,000
-3% -$252K ﹤0.01% 1333
2015
Q2
$15.2M Buy
511,100
+10,500
+2% +$312K ﹤0.01% 1226
2015
Q1
$11M Buy
500,600
+3,000
+0.6% +$66.1K ﹤0.01% 1311
2014
Q4
$13.7M Buy
497,600
+80,700
+19% +$2.21M ﹤0.01% 1237
2014
Q3
$8.08M Sell
416,900
-312,800
-43% -$6.06M ﹤0.01% 1358
2014
Q2
$12.4M Buy
729,700
+701,500
+2,488% +$11.9M ﹤0.01% 1263
2014
Q1
$400K Sell
28,200
-8,600
-23% -$122K ﹤0.01% 2014
2013
Q4
$430K Buy
+36,800
New +$430K ﹤0.01% 1973